Results 61 to 70 of about 24,077 (209)

An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Ulotaront is an investigational trace amine‐associated receptor 1 (TAAR1) agonist demonstrated to slow gastric emptying in schizophrenia patients with metabolic syndrome (MetSyn) and prediabetes type 2. Here we evaluate the effects of ulotaront on glucose‐insulin dynamics in schizophrenia patients with MetSyn and prediabetes.
Snezana Milanovic, Robert Lew, Kuangnan Xiong, Emily Casavant, Gerard Galluppi, Yu‐Luan Chen, Yongquan Lai, Manu Chakravarthy, Clay Dehn, Kenneth Koblan, Seth C. Hopkins   +10 more
wiley   +1 more source

Health-Related Social Needs in Patients With Gastroparesis: Relationships to Symptom Severity and Quality of Life

Gastro Hep Advances
Background and Aims: Patients with health-related social needs (HRSNs) experience barriers to health care services. To identify areas of intervention, we need to understand the impact of HRSN in patients with gastroparesis.
Susie O. Lee, Alexandra C. Barrett, Paul J. Silver, Henry P. Parkman   +3 more
doaj   +1 more source

Gastroparesis: Prevalence, Clinical Significance and Treatment

Canadian Journal of Gastroenterology, 2001
The application of novel techniques to quantify gastric motor function and gastric emptying has yielded important insights into the prevalence, pathogenesis and clinical sequelae of gastroparesis.
Michael Horowitz, Yu-Chung Su, Christopher K Rayner, Karen L Jones   +3 more
doaj   +1 more source

Gastroparesia diabética [PDF]

, 1997
Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Disciplinas de Endocrinologia e MetabologiaUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Disciplinas de Epidemiologia ClínicaUNIFESP, EPM, Disciplinas de ...
Cesarini, Paulo Roberto, Dib, Sergio Atala, Ferreira, Sandra Roberta Gouvea   +2 more
core   +2 more sources

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Current status and research progress of diagnosis and treatment of gastroparesis after gastric cancer surgery

生物医学转化
Radical surgery is the cornerstone for achieving curative outcomes in early and locoregionally advanced gastric cancer. However, while radical surgery removes the tumor, it also carries the risk of postoperative complications. Gastroparesis is one of the
Han Xue, Wang Wanqing, Zhao Lulu, Niu Penghui, Chen Yingtai   +4 more
doaj   +1 more source

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report [PDF]

, 2017
There is a frequently encountered subset of hypothyroid patients who are refractory to standard thyroid hormone replacement treatment and require unexpectedly high doses of levothyroxine.
Benvenga, S, Centanni, Marco, Sachmechi, I.   +2 more
core   +1 more source

Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims While discontinuation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) before esophagogastroduodenoscopy (EGD) is not universally mandated, safety concerns persist. Evidence remains insufficient for managing specific patient subgroups, particularly in Asian populations. We aimed to provide evidence for stratified risk assessment in
Hiroyuki Hisada, Kazuhiko Ikeuchi, Yosuke Tsuji, Nobutake Yamamichi, Naomi Kakushima, Kazuya Okushin, Seiichi Yakabi, Chihiro Takeuchi, Daisuke Ohki, Hiroya Mizutani, Yuko Miura, Dai Kubota, Takeya Tsutsumi, Mitsuhiro Fujishiro   +13 more
wiley   +1 more source

Endoscopic findings and psychometric abnormalities: what is the relationship in upper endoscopic outpatients? [PDF]

, 2015
Background. Psychological disorders are often associated with diseases of the upper digestive tract. Although emotions can influence gastrointestinal function in healthy individuals, psychological setting in upper gastrointestinal patients are unclear ...
ANGELINI, Rita, FILIPPINI, Angelo, MARIANETTI, Massimo, MINA, Concetta, PETRARCA, LAURA, PONTONE, Paolo, PONTONE, Stefano, RIDOLA, LORENZO, STANDOLI, MONICA   +8 more
core   +1 more source

Real‐world incidence and risk factors of level 3 (severe) hypoglycaemia in adults with type 1 or 2 diabetes (iNPHORM, United States)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Level 3 (severe) hypoglycaemia is a serious, yet preventable, complication of insulin‐ or secretagogue‐treated diabetes. However, real‐world insight into its incidence and risk factors remains limited. We analysed data from the iNPHORM study to address this gap.
Alexandria Ratzki‐Leewing, Jason E. Black, Jasminder Bhatti, Bridget L. Ryan, Guangyong Zou, Yu Kuei Lin, Shuo J. Huang, Rozalina G. McCoy, Stewart B. Harris   +8 more
wiley   +1 more source